Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3059 (LINC03059, also known as RP11-108M12.3) is a human gene encoding a long non-coding RNA molecule located at chromosome 14q22.3 (chr14:56,953,826-57,112,685)[3][7][9]. It is classified as a lncRNA, implying it does not code for a protein and functions primarily in gene regulation by modulating transcription, RNA stability, and chromatin structure[9][11]. LINC03059 has approved nomenclature according to HGNC (HGNC:56366)[1][9], and its RNA-based nature means it is not considered a canonical therapeutic target like receptors or enzymes. While long intergenic non-coding RNAs are increasingly recognized for roles in cell cycle regulation, apoptosis, immune response, and cancer biology, specific functional data for LINC03059, including its downstream biological pathways or disease associations, remain uncharacterized as of late 2025[11]. No drugs, biomarkers, or safety considerations have been formally attributed to this molecule.
Null. There are no known mechanisms of action for drugs targeting LINC03059
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3059 (LINC03059).